Tacrolimus
Tacrolimus is a topical ointment available in 0.03% and 0.1% strengths, prescribed as an immunosuppressant to help manage skin conditions like eczema. Manufactured by Mayne Pharma Inc. and E. Fougera & Co., it's approved under ANDA200744 for prescription use. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Tacrolimus is a topical ointment available in 0.03% and 0.1% strengths, prescribed as an immunosuppressant to help manage skin conditions like eczema. Manufactured by Mayne Pharma Inc. and E. Fougera & Co., it's approved under ANDA200744 for prescription use. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Tacrolimus",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Tacrolimus — ANDA 090802 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090802"
}
]
|
| identifier | ANDA090802 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-manufacturers",
"fda",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Tacrolimus |
